Publication: Five-year follow-up of prostate cancer in Siriraj Hospital
6
item.page.dc.date.issued
2000-12-01
item.page.dc.type
item.page.dc.identifier.issn
01252208
item.page.dc.identifier.other
2-s2.0-0034153747
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Journal of the Medical Association of Thailand. Vol.83, No.3 (2000), 236-242
punsarn.item.page.citation
Suchai Soontrapa, Anuphan Tantiwong, Sunai Leewansangtong, Thongchai Bhanalaph Five-year follow-up of prostate cancer in Siriraj Hospital. Journal of the Medical Association of Thailand. Vol.83, No.3 (2000), 236-242. Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/26058
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Five-year follow-up of prostate cancer in Siriraj Hospital
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
Objective: To determine the clinical features, tumor characteristics, and treatment outcomes of Thai men with prostate cancer. Material and Method: We retrospectively evaluated the clinical features, tumor characteristics, and treatment outcomes of 95 patients who were registered in Siriraj Hospital from 1993 to 1995. A survival end point in each stage was determined. Results: The mean age was 72.37. The distributions of stage were 7.5 per cent for stage A, 1.1 per cent for stage B, 67.7 per cent for stage C, and 23.7 per cent for stage D. The prognosis of a clinical localized disease appeared good. Most patients with a urinary symptom were highly associated with stage C or stage D disease and were treated by hormonal therapy. With a maximal follow-up of 60 months, the median survival of stage C and D patients was 45 and 12 months, respectively. Conclusion: Most Thai patients with prostate cancer were older than the life expectancy of Thai men. They presented with urinary symptoms and had locally advanced or advanced disease. With hormonal treatment, their prognoses were not impressive.